FdaApplication

NDA 219293

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAZURITY PHARMACEUTICALS INC
application_typeNDA
approval_date2024-11-07

Products (2)

ProductActive ingredientStrengthDosage form
DANZITENNILOTINIB TARTRATEEQ 95MG BASETABLET;ORAL
DANZITENNILOTINIB TARTRATEEQ 71MG BASETABLET;ORAL

2 products